QTREX Quantum Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $289KTTM through 31 Dec 2025
Net Income -$13.2MTTM through 31 Dec 2025
Free Cash Flow -$10MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 0.7% |
| Operating Margin | -4,713.8% |
| Net Margin | -4,574.4% |
Balance Sheet Health
Current Ratio1.56x
Cash & Equivalents$3.2M
Quality Metrics
Piotroski F-Score3 / 9
FCF Margin-3,447.8%
Multi-Year Trend
RevenueFY2025: $289K
Diluted EPS-$0.45TTMFY2025: $-0.45
Dividend
No dividend
Capital Allocation
Capex Intensity35.6%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Medical (INSPIRA ART100 Systems and Carts) | $289K | View detailsMonetization and strategic alternatives are being evaluated for the legacy medical technology portfolio as the company pivots to quantum computing connectivity. | |
| Quantum Computing Connectivity (AME Platform) | $0 | View detailsDeveloping high-density, thermally optimized cryogenic interconnect solutions for quantum computing dilution cryostats and advancing AME applications for defense, aerospace, and space environments. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.